CRP and triple-negative breast carcinoma: The in vitro model showed that CRP activates the integrin α2 signaling pathways, demonstrating a role for CRP in the growth, acquisition of adhesive, and invasive phenotypes in breast and triple-negative breast cancer cells [33].